Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

May 16, 2024

SELL
$2.74 - $7.35 $231,743 - $621,648
-84,578 Closed
0 $0
Q3 2023

May 16, 2024

SELL
$2.65 - $3.31 $154,094 - $192,473
-58,149 Reduced 40.74%
84,578 $261 Million
Q1 2023

May 16, 2024

BUY
$2.56 - $3.55 $365,381 - $506,680
142,727 New
142,727 $424 Million

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $72.3M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Connective Capital Management, LLC Portfolio

Follow Connective Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Capital Management, LLC with notifications on news.